|Number of Estimates|
Abiomed Europe GmbH, Aachen / Germany, as affiliate of Abiomed Inc. headquartered in Danvers, Massachusetts, USA, is a leading medical technology company in the field of circulatory support. Its products aim to enable heart recovery by improving blood circulation and/or heart pump function.
Market Cap: 14.7 Billion
Primary Exchange: NASDAQ/NGS (GLOBAL SELECT MARKET)
Shares Outstanding: 45.3 Million
Dividend: 0.0 (0.0%)
Industry: Surgical and Medical Instrument Manufacturing
Longest drawdown: 809 trading days
From: 2018-09-28 To: 2021-07-29
Impella Featured as an Innovative Technology at U.S. Capitol Event Showcasing Improvements to Women's Health
via: Business Wire at 2019-06-13 10:00:00:000
Abiomeds(NASDAQ:ABMD) Impella platform is being featured today at a Washington, D.C., event showcasing innovations in medical technology that improve healthcare for women. Abiomeds participation supports its Womens Initiative for Heart Recovery , which provid… read more...
|Ex-Date||Payment Date||Record Date||Declared Date||Amount||Flag||Dividend Type||Qualified||Indicated|
|Ex-Date||Declared Date||Record Date||Payment Date||Ratio||To Factor||For Factor|